FDA orders new Nonoxynol-9 warning

Dec 18, 2007

The U.S. Food and Drug Administration issued a final rule Tuesday requiring manufacturers of nonoxynol-9, or N9, to add a warning to the product's label.

The FDA said the warning must state the over-the-counter vaginal contraceptive and spermicidal product does not protect against infection by the human immunodeficiency virus that causes AIDS, nor does it protect against other sexually transmitted diseases.

Stand-alone spermicides include gels, foams, films, or inserts containing N9 that are used by themselves for contraception.

The federal agency said consumers can protect themselves from the transmission of STDs and HIV by practicing abstinence, being in a monogamous relationship with an uninfected partner and by using condoms consistently and correctly.

The FDA said it issued the rule to correct misconceptions that the chemical N9 protects against sexually transmitted diseases, including HIV infection.

In addition, the FDA is requiring the labels warn consumers that N9 in stand-alone vaginal contraceptives and spermicides can irritate the vagina and rectum, which may increase the risk of contracting HIV/AIDS from an infected partner.

Copyright 2007 by United Press International

Explore further: FDA to start regulating lab-developed tests

add to favorites email to friend print save as pdf

Related Stories

Tech companies eye security that goes beyond passwords

Jun 19, 2013

In late February, a thief or thieves cracked into Evernote's digital vault filled with log-ins, passwords and email addresses belonging to 50 million users. It was a shocking cyberattack considering the Redwood City, Calif., ...

HPV vaccination prevents genital warts in males

Feb 04, 2011

(PhysOrg.com) -- A new international study shows the human papillomavirus (HPV) vaccine protects against genital warts and other lesions associated with HPV in males. HPV is the most common sexually transmitted disease and ...

Recommended for you

FDA to start regulating lab-developed tests

1 hour ago

(AP)—The Food and Drug Administration announced Thursday it will begin regulating laboratory-developed tests, a growing class of medical diagnostics that have never before been subject to federal oversight.

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

User comments : 0